TP53 and neoplasm: Eight out of 10 (80.0%) PSCC with diffuse overexpression pattern were enriched in pathogenic/likely pathogenic variants of TP53, followed by those with null pattern (2/4; 50.0%), cytoplasmic pattern (1/2; 50.0%), while the only tumour with basal overexpression harboured the variant of uncertain significance.